THERAPEUTIC TARGETING OF SPLICEOSOMAL-MUTANT ACQUIRED BONE MARROW FAILURE DISORDER

$506,368FY2016Department of DefenseDOD

Sloan-Kettering Institute For Cancer Research

Investigators